News
Eli Lilly’s oral drug orforglipron may win FDA approval in the final months of 2025, offering a lower-cost alternative to injectable obesity drugs
Donald Trump sues NYT and Penguin for defamation and libel claiming reputational harm and loss of business worth billions
- 1
- 2
Top Picks
Eli Lilly’s oral drug orforglipron may win FDA approval in the final months of 2025, offe…
Donald Trump sues NYT and Penguin for defamation and libel claiming reputational harm and…
Advertisement
Videos News
- 1
Articles
- 1